ArticleMolecular biology reports2025
A rare variant of USP9X associated with female-restricted X-linked syndromic intellectual disability.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundUSP9X gene variations have been associated with the rare syndrome female-restricted X-linked syndromic intellectual disability (MRXS99F). Loss-of-function mutations in USP9X gene is primarily characterized by development delay, speech and motor disorders, special facial features and multiple congenital malformations. METHODS AND
resultsWe reported a newborn who presented with special facial features and developmental delay. We performed whole-genome sequencing and identified a rare novel heterozygous USP9X variant, c.4071-4077delCTTTACT (p.Thr1359Trpfs*19). To date, only seven USP9X variants in infants have been reported. Affected individuals typically exhibit a spectrum of congenital anomalies, including craniofacial dysmorphisms (such as hypertelorism, flat nasal bridge, and cleft palate), skeletal abnormalities (such as limb shortening, scoliosis, and rib anomalies), and neurological deficits (including severe intellectual disability, epilepsy, and motor delay). The radio logical tests revealed structural anomalies, such as corpus callosum agenesis and congenital hip dysplasia.
conclusionsThis study expands the genotypic and clinical phenotypic spectrum of USP9X-related MRXS99F and reinforces the utility of whole-genome sequencing in early diagnosis and genetic counseling.
Indexed as
Identifiers
41240171What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.